Variation in intention-to-treat survival by MELD subtypes: All models created for end-stage liver disease are not equal
Year: 2024
Type: article
Study design: Observational Study
Source: Journal of Hepatology
Institutions: Baylor University Medical Center, University of Pennsylvania, Baylor Scott & White Health, University of Miami, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Mayo Clinic
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: ENFERMEDAD HEPÁTICA POR CONSUMO DE ALCOHOL: MECANISMOS PATOGÉNICOS, RELACIÓN CON INFLAMACIÓN Y SÍNDROME METABÓLICO, EFECTOS DE LA ABSTINENCIA y EVALUACIÓN DE NUEVOS MÉTODOS TERAPÉUTICOS, G7016478031, 1/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE), Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial, Impact of mammalian target of rapamycin inhibitor therapy on aging-related outcomes, Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort, 2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
OpenAlex ID: W4401829875